866-897-8297

Call Is Confidential & Toll Free

Latuda

Latuda is an atypical antipsychotic developed by Dainippon Sumitomo Pharma. It was approved by the U.S. Food and Drug Administration (FDA ) for treatment of schizophrenia on October 29, 2010 and is currently pending approval for the treatment of bipolar disorder in the United States. (Wikipedia)

Latuda is a benzothiazol derivative that is an antagonist and binds with high affinity to Dopamine-2 (D2) (Ki = 0.994 nM), 5-HT2A (Ki = 0.47 nM) receptors, and 5-HT7 receptors (Ki = 0.495 nM). It also binds with moderate affinity to alpha-2C adrenergic receptors (Ki = 10.8 nM) and is a partial agonist at 5-HT1A receptors (Ki = 6.38 nM). Its actions on histaminergic and muscarinic receptors are negligible.

Imprints


Drug: Latuda
Strength: 40 Mg
Pill Imprint: L 40
Color: White
Shape: Round

View Images & Details

Drug: Latuda
Strength: 80 Mg
Pill Imprint: L 80
Color: Green
Shape: Elliptical / Oval

View Images & Details

Drug: Latuda
Strength: 20 Mg
Pill Imprint: L 20
Color: White
Shape: Round

View Images & Details

Drug: Latuda
Strength: 120 Mg
Pill Imprint: L 120
Color: White
Shape: Elliptical / Oval

View Images & Details

Drug: Latuda
Strength: 60 Mg
Pill Imprint: L 60
Color: White
Shape: Capsule-shape

View Images & Details
Disclaimer: We strive to ensure that the content on pilladdictions.com is current and factual at the time it was written. However, because new information and discoveries are always becoming available, we are not making any representations or warranties with respect to this content. Please always rely on the guidance of your physician for information about the drugs you are taking and the impacts they may or may not have on your health.

Questions About Prescription Drug Addiction?

(888) 740-2069

Questions About Prescription Drug Addiction?